{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:53:07Z","timestamp":1790545987281,"version":"4.1.0"},"reference-count":41,"publisher":"American Diabetes Association","issue":"6","license":[{"start":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T00:00:00Z","timestamp":1558310400000},"content-version":"vor","delay-in-days":41,"URL":"http:\/\/www.diabetesjournals.org\/content\/license"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["T32-DK-063687"],"award-info":[{"award-number":["T32-DK-063687"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K23-DK-116720"],"award-info":[{"award-number":["K23-DK-116720"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01-DK-61212"],"award-info":[{"award-number":["U01-DK-61212"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,6,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>Elevated serum uric acid (SUA) is increasingly recognized as a risk factor for kidney disease in adults with diabetes, but data in youth are limited. We hypothesized that elevated SUA predicts development of elevated urinary albumin excretion (UAE) and hypertension over time in teens with type 2 diabetes (T2D).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                    <jats:p>Serum creatinine, cystatin C, SUA, and the urine albumin-to-creatinine ratio (UACR) were assessed in 539 obese youth, ages 12\u201317 years, with T2D duration &amp;lt;2 years at baseline in the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) study. Estimated glomerular filtration rate (eGFR) was calculated using creatinine and cystatin C. Hypertension was defined as systolic or diastolic blood pressure \u2265130\/80 mmHg and elevated UAE as UACR \u226530 mg\/g. Cox proportional hazards models evaluated the relationship between SUA and outcome variables longitudinally over an average follow-up of 5.7 years, adjusting for age, sex, race\/ethnicity, BMI, HbA1c, eGFR, ACE inhibitor\/angiotensin receptor blocker use, and TODAY treatment group assignment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>At baseline, hyperuricemia (\u22656.8 mg\/dL) was present in 25.6% of participants, hypertension in 18.7%, and elevated UAE in 6.1%. During follow-up of up to 7 years, hypertension developed in 37.4% and UAE in 18.0%. Higher baseline SUA increased the risk of incident hypertension (hazard ratio [HR] 1.19, 95% CI 1.03\u20131.38, per 1 mg\/dL increase in SUA) and elevated UAE (HR 1.24, 95% CI 1.03\u20131.48) in adjusted models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>Hyperuricemia was common in youth with T2D. Higher baseline SUA independently increased the risk for onset of hypertension and elevated UAE. Research is needed to determine whether SUA-lowering therapies can impede development of diabetic kidney disease and hypertension in T2D youth.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/dc18-2147","type":"journal-article","created":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T23:15:14Z","timestamp":1554851714000},"page":"1120-1128","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":102,"title":["Elevated Serum Uric Acid Is Associated With Greater Risk for Hypertension and Diabetic Kidney Diseases in Obese Adolescents With Type 2 Diabetes: An Observational Analysis From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study"],"prefix":"10.2337","volume":"42","clinical-trial-number":[{"clinical-trial-number":"nct00081328","registry":"10.18810\/clinical-trials-gov","type":"results"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5160-2947","authenticated-orcid":false,"given":"Petter","family":"Bjornstad","sequence":"first","affiliation":[{"name":"University of Colorado Anschutz Medical Campus and Children\u2019s Hospital Colorado, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9675-3001","authenticated-orcid":false,"given":"Lori","family":"Laffel","sequence":"additional","affiliation":[{"name":"Joslin Diabetes Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Lynch","sequence":"additional","affiliation":[{"name":"The University of Texas Health Science Center at San Antonio, San Antonio, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4223-8407","authenticated-orcid":false,"given":"Laure","family":"El ghormli","sequence":"additional","affiliation":[{"name":"George Washington University Biostatistics Center, Rockville, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth S.","family":"Weinstock","sequence":"additional","affiliation":[{"name":"Department of Medicine, State University of New York Upstate Medical University, Syracuse, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherida E.","family":"Tollefsen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Saint Louis University Health Sciences Center, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen J.","family":"Nadeau","sequence":"additional","affiliation":[{"name":"University of Colorado Anschutz Medical Campus and Children\u2019s Hospital Colorado, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the TODAY Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2019,4,9]]},"reference":[{"key":"2022031300004871500_B1","first-page":"A8, e1-526","article-title":"US Renal Data System 2010 Annual Data Report","volume-title":"Am J Kidney Dis","author":"Collins","year":"2011"},{"key":"2022031300004871500_B2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jama.2017.0686","article-title":"Association of type 1 diabetes vs type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood","volume":"317","author":"Dabelea","year":"2017","journal-title":"JAMA"},{"key":"2022031300004871500_B3","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.2337\/dc12-2420","article-title":"Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial","volume":"36","author":"TODAY Study Group","year":"2013","journal-title":"Diabetes Care"},{"key":"2022031300004871500_B4","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2337\/dc15-0991","article-title":"An inverse relationship between age of type 2 diabetes onset and complication risk and mortality: the impact of youth-onset type 2 diabetes","volume":"39","author":"Al-Saeed","year":"2016","journal-title":"Diabetes Care"},{"key":"2022031300004871500_B5","first-page":"Svii, S1\u2013S305","article-title":"US Renal Data System 2015 Annual Data Report: epidemiology of kidney disease in the United States","volume-title":"Am J Kidney Dis","author":"Saran","year":"2016"},{"key":"2022031300004871500_B6","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00592-014-0611-1","article-title":"Serum uric acid predicts vascular complications in adults with type 1 diabetes: the coronary artery calcification in type 1 diabetes study","volume":"51","author":"Bjornstad","year":"2014","journal-title":"Acta Diabetol"},{"key":"2022031300004871500_B7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1161\/HYPERTENSIONAHA.117.10370","article-title":"Uric acid is a strong risk marker for developing hypertension from prehypertension: a 5-year Japanese Cohort Study","volume":"71","author":"Kuwabara","year":"2018","journal-title":"Hypertension"},{"key":"2022031300004871500_B8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/jch.12026","article-title":"Serum uric acid, inflammation, and nondipping circadian pattern in essential hypertension","volume":"15","author":"Turak","year":"2013","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2022031300004871500_B9","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s00125-015-3650-4","article-title":"Fructose and uric acid in diabetic nephropathy","volume":"58","author":"Bjornstad","year":"2015","journal-title":"Diabetologia"},{"key":"2022031300004871500_B10","doi-asserted-by":"crossref","first-page":"F992","DOI":"10.1152\/ajprenal.00645.2016","article-title":"U-shaped relationship between serum uric acid levels and intrarenal hemodynamic parameters in healthy subjects","volume":"312","author":"Uedono","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"2022031300004871500_B11","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jpeds.2012.12.078","article-title":"Uric acid and the origins of hypertension","volume":"162","author":"Feig","year":"2013","journal-title":"J Pediatr"},{"key":"2022031300004871500_B12","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1056\/NEJMoa1614329","article-title":"Single-nephron glomerular filtration rate in healthy adults","volume":"376","author":"Denic","year":"2017","journal-title":"N Engl J Med"},{"key":"2022031300004871500_B13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1523-1755.2004.00729.x","article-title":"Hypothesis: uric acid, nephron number, and the pathogenesis of essential hypertension","volume":"66","author":"Feig","year":"2004","journal-title":"Kidney Int"},{"key":"2022031300004871500_B14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1053\/j.ajkd.2017.07.015","article-title":"Insulin sensitivity and diabetic kidney disease in children and adolescents with type 2 diabetes: an observational analysis of data from the TODAY Clinical Trial","volume":"71","author":"Bjornstad","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"2022031300004871500_B15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1399-5448.2007.00237.x","article-title":"Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes","volume":"8","author":"Zeitler","year":"2007","journal-title":"Pediatr Diabetes"},{"key":"2022031300004871500_B16","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(09)60883-7","article-title":"Gout","volume":"375","author":"Richette","year":"2010","journal-title":"Lancet"},{"key":"2022031300004871500_B17","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1210\/jc.2010-2813","article-title":"Surrogate estimates of insulin sensitivity in obese youth along the spectrum of glucose tolerance from normal to prediabetes to diabetes","volume":"96","author":"George","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031300004871500_B18","doi-asserted-by":"crossref","first-page":"552","DOI":"10.2215\/CJN.04180510","article-title":"Which creatinine and cystatin C equations can be reliably used in children","volume":"6","author":"Bacchetta","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"2022031300004871500_B19","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2215\/CJN.06460710","article-title":"Pediatric GFR estimating equations applied to adolescents in the general population","volume":"6","author":"Fadrowski","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"2022031300004871500_B20","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/ndt\/gfv454","article-title":"An estimated glomerular filtration rate equation for the full age spectrum","volume":"31","author":"Pottel","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"2022031300004871500_B21","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1399-5448.2011.00841.x","article-title":"Determinants of glycemic control in youth with type 2 diabetes at randomization in the TODAY study","volume":"13","author":"Bacha","year":"2012","journal-title":"Pediatr Diabetes"},{"key":"2022031300004871500_B22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1053\/j.ackd.2014.03.003","article-title":"Cardiovascular complications of diabetic kidney disease","volume":"21","author":"P\u00e1lsson","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"key":"2022031300004871500_B23","author":"Swales","year":"1995"},{"key":"2022031300004871500_B24","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1523-1755.2005.00459.x","article-title":"Correlation of uric acid and urinary albumin excretion rate in patients with type 2 diabetes mellitus in Taiwan","volume":"68","author":"Tseng","year":"2005","journal-title":"Kidney Int"},{"key":"2022031300004871500_B25","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/01.HYP.0000248752.08807.4c","article-title":"Uric acid and the development of hypertension: the Normative Aging Study","volume":"48","author":"Perlstein","year":"2006","journal-title":"Hypertension"},{"key":"2022031300004871500_B26","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1161\/HYPERTENSIONAHA.111.183244","article-title":"Uric acid level and elevated blood pressure in US adolescents: National Health and Nutrition Examination Survey, 1999-2006","volume":"59","author":"Loeffler","year":"2012","journal-title":"Hypertension"},{"key":"2022031300004871500_B27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000368507","article-title":"Relationship between serum uric acid levels and intrarenal hemodynamic parameters","volume":"40","author":"Uedono","year":"2015","journal-title":"Kidney Blood Press Res"},{"key":"2022031300004871500_B28","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/ajh\/1.4.335","article-title":"Glomeruli and blood pressure. Less of one, more the other","volume":"1","author":"Brenner","year":"1988","journal-title":"Am J Hypertens"},{"key":"2022031300004871500_B29","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/j.1523-1755.2004.00909.x","article-title":"Uric acid and the state of the intrarenal renin-angiotensin system in humans","volume":"66","author":"Perlstein","year":"2004","journal-title":"Kidney Int"},{"key":"2022031300004871500_B30","doi-asserted-by":"crossref","first-page":"F991","DOI":"10.1152\/ajprenal.00283.2001","article-title":"Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism","volume":"282","author":"Mazzali","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"2022031300004871500_B31","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.numecd.2016.12.008","article-title":"Serum uric acid is not independently associated with plasma renin activity and plasma aldosterone in hypertensive adults","volume":"27","author":"Mul\u00e9","year":"2017","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2022031300004871500_B32","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/HJH.0000000000001212","article-title":"Serum uric acid and the relationship with subclinical organ damage in adults","volume":"35","author":"Lambert","year":"2017","journal-title":"J Hypertens"},{"key":"2022031300004871500_B33","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.2337\/dc09-0288","article-title":"Association between serum uric acid and development of type 2 diabetes","volume":"32","author":"Kodama","year":"2009","journal-title":"Diabetes Care"},{"key":"2022031300004871500_B34","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1161\/01.HYP.0000161184.10873.ea","article-title":"Serum uric acid and target organ damage in primary hypertension","volume":"45","author":"Viazzi","year":"2005","journal-title":"Hypertension"},{"key":"2022031300004871500_B35","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/hr.2013.134","article-title":"Sex differences in the association between serum uric acid levels and cardiac hypertrophy in patients with chronic kidney disease","volume":"37","author":"Yoshitomi","year":"2014","journal-title":"Hypertens Res"},{"key":"2022031300004871500_B36","doi-asserted-by":"crossref","first-page":"e28641","DOI":"10.1371\/journal.pone.0028641","article-title":"Clinical and functional characterization of URAT1 variants","volume":"6","author":"Tasic","year":"2011","journal-title":"PLoS One"},{"key":"2022031300004871500_B37","first-page":"128","article-title":"Effect of allopurinol in decreasing proteinuria in type 2 diabetic patients","volume":"4","author":"Momeni","year":"2010","journal-title":"Iran J Kidney Dis"},{"key":"2022031300004871500_B38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/HYPERTENSIONAHA.111.171488","article-title":"Effect of a reduction in uric acid on renal outcomes during losartan treatment: a post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mellitus with the Angiotensin II Antagonist Losartan Trial","volume":"58","author":"Miao","year":"2011","journal-title":"Hypertension"},{"key":"2022031300004871500_B39","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/jama.300.8.924","article-title":"Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial","volume":"300","author":"Feig","year":"2008","journal-title":"JAMA"},{"key":"2022031300004871500_B40","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.2337\/db17-0168","article-title":"Renal and vascular effects of uric acid lowering in normouricemic patients with uncomplicated type 1 diabetes","volume":"66","author":"Lytvyn","year":"2017","journal-title":"Diabetes"},{"key":"2022031300004871500_B41","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s11892-013-0381-0","article-title":"Uric acid lowering to prevent kidney function loss in diabetes: the Preventing Early Renal Function Loss (PERL) allopurinol study","volume":"13","author":"Maahs","year":"2013","journal-title":"Curr Diab Rep"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/care.diabetesjournals.org\/syndication\/doi\/10.2337\/dc18-2147","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/42\/6\/1120\/553051\/dc182147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/42\/6\/1120\/553051\/dc182147.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T22:00:50Z","timestamp":1647122450000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/42\/6\/1120\/36030\/Elevated-Serum-Uric-Acid-Is-Associated-With"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,9]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,4,9]]},"published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc18-2147","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,9]]}}}